As of Feb 05
| -0.08 / -2.56%|
The 6 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 16.38, with a high estimate of 27.00 and a low estimate of 11.00. The median estimate represents a +438.65% increase from the last price of 3.04.
The current consensus among 6 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.